Liquid biopsy can detect circulating cancer cells or tumor cell-derived DNA at various stages
of cancer. The fluid from these biopsies contains extracellular vesicles (EVs), such as …

Various cell types release extracellular vesicles (EVs), known as exosomes and
microvesicles, which facilitate cell-to-cell communication by transferring proteins and nucleic …

Cancer is a leading cause of death worldwide and cancer incidence and mortality are
rapidly growing. These massive amounts of cancer patients require rapid diagnosis and …

Introduction: In recent years, extensive research has been conducted on using exosomes as
biomarkers for cancer detection. Exosomes are 40–150 nm-sized extracellular vesicles …

Liquid biopsy especially that of exosomes carries tumor-specific molecules and provides
useful information during tumor development and progression in “real time.” Exosomes are …

Exosomes are emerging as a new type of cancer biomarkers. Exosome is a bilayered nano-
sized vesicle secreted by various living cells in all body fluids. Based on the expanding …

Cancer is a complex disease that is associated with genetic aberrations and subsequent
cellular and noncellular host responses. Tumors harbor diverse cell types that engage in a …

Cancer diagnosis and therapy is steadily improving. Still, diagnosis is frequently late and
diagnosis and follow-up procedures mostly are time-consuming and expensive. Searching …

Exosomes, the bilayer-lipid-membrane microvesicles are well known for intercellular
communications. They are considered to be involved in tumorigenesis, progression and …

Early detection, characterization and monitoring of cancer are possible by using
extracellular vesicles (EVs) isolated from non-invasively obtained liquid biopsy samples …